The ubiquitin-proteasome system in huntington's disease: Are proteasomes impaired, initiators of disease, or coming to the rescue?

Biochemistry Research International

Volumn , Issue , 2012, Pages

  Schipper Krom, Sabine ^a   Juenemann, Katrin ^a   Reits, Eric A J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867386032     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2012/837015     Document Type: Review

References (114)

1. Ross C. A., When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 1995 15 3 493 496 2-s2.0-0029089172
2. Zoghbi H. Y., Orr H. T., Glutamine repeats and neurodegeneration. Annual Review of Neuroscience 2000 23 217 247 2-s2.0-0034094873 10.1146/annurev.neuro. 23.1.217
3. Harjes P., Wanker E. E., The hunt for huntingtin function: interaction partners tell many different stories. Trends in Biochemical Sciences 2003 28 8 425 433 2-s2.0-0041656292 10.1016/S0968-0004(03)00168-3
4. Gerber H. P., Seipel K., Georgiev O., Hofferer M., Hug M., Rusconi S., Schaffner W., Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 1994 263 5148 808 811 2-s2.0-23444458415
5. Duyao M., Ambrose C., Myers R., Novelletto A., Persichetti F., Frontali M., Folstein S., Ross C., Franz M., Abbott M., Gray J., Conneally P., Young A., Penney J., Hollingsworth Z., Shoulson I., Lazzarini A., Falek A., MacDonald M., Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genetics 1993 4 4 387 392 2-s2.0-0027240431 10.1038/ng0893-387
6. Snell R. G., MacMillan J. C., Cheadle J. P., Fenton I., Lazarou L. P., Davies P., MacDonald M. E., Gusella J. F., Harper P. S., Shaw D. J., Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nature Genetics 1993 4 4 393 397 2-s2.0-0027261537 10.1038/ng0893-393
7. Ordway J. M., Tallaksen-Greene S., Gutekunst C. A., Bernstein E. M., Cearley J. A., Wiener H. W., Dure L. S., Lindsey R., Hersch S. M., Jope R. S., Albin R. L., Detloff P. J., Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 1997 91 6 753 763 2-s2.0-0031469707 10.1016/S0092-8674(00)80464-X
8. Ikeda H., Yamaguchi M., Sugai S., Aze Y., Narumiya S., Kakizuka A., Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genetics 1996 13 2 198 202 2-s2.0-0030058208
9. Cattaneo E., Rigamonti D., Goffredo D., Zuccato C., Squitieri F., Sipione S., Loss of normal huntingtin function: new developments in Huntington's disease research. Trends in Neurosciences 2001 24 3 182 188 2-s2.0-0035282594 10.1016/S0166-2236(00)01721-5
10. Zuccato C., Valenza M., Cattaneo E., Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiological Reviews 2010 90 3 905 981 2-s2.0-77955643169 10.1152/physrev.00041.2009
11. Vonsattel J. P., Myers R. H., Stevens T. J., Neuropathological classification of Huntington's disease. Journal of Neuropathology and Experimental Neurology 1985 44 6 559 577 2-s2.0-0022395922
12. Walker F. O., Huntington's disease. Lancet 2007 369 9557 218 228 2-s2.0-33846225133 10.1016/S0140-6736(07)60111-1
13. Mendez M. F., Huntington's disease: update and review of neuropsychiatric aspects. International Journal of Psychiatry in Medicine 1994 24 3 189 208 2-s2.0-0028608877
14. Han I., You Y., Kordower J. H., Brady S. T., Morfini G. A., Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features. Journal of Neurochemistry 2010 113 5 1073 1091 2-s2.0-77951925392 10.1111/j.1471-4159.2010.06672.x
15. Ehrnhoefer D. E., Sutton L., Hayden M. R., Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease. The Neuroscientist 2011 17 475 492 10.1177/1073858410390378
16. Di Prospero N. A., Fischbeck K. H., Therapeutics development for triplet repeat expansion diseases. Nature Reviews Genetics 2005 6 10 756 765 2-s2.0-25844506224 10.1038/nrg1690
17. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., Aronin N., Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997 277 5334 1990 1993 2-s2.0-0030752709 10.1126/science.277.5334.1990
18. Ross C. A., Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 1997 19 6 1147 1150 2-s2.0-0031446233 10.1016/S0896-6273(00)80405-5
19. Ross C. A., Poirier M. A., What is the role of protein aggregation in neurodegeneration? Nature Reviews Molecular Cell Biology 2005 6 11 891 898 2-s2.0-27644596641 10.1038/nrm1742
20. Sánchez I., Mahlke C., Yuan J., Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 2003 421 6921 373 379 2-s2.0-0037461730 10.1038/nature01301
21. Arrasate M., Mitra S., Schweitzer E. S., Segal M. R., Finkbeiner S., Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004 431 7010 805 810 2-s2.0-7244236320 10.1038/nature02998
22. Goldberg A. L., Protein degradation and protection against misfolded or damaged proteins. Nature 2003 426 6968 895 899 2-s2.0-0346727127 10.1038/nature02263
23. Seglen P. O., Bohley P., Autophagy and other vacuolar protein degradation mechanisms. Experientia 1992 48 2 158 172 2-s2.0-0026584008
24. Martinez-Vicente M., Cuervo A. M., Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurology 2007 6 4 352 361 2-s2.0-33847652900 10.1016/S1474-4422(07)70076-5
25. Xie Z., Klionsky D. J., Autophagosome formation: core machinery and adaptations. Nature Cell Biology 2007 9 10 1102 1109 2-s2.0-34848886914 10.1038/ncb1007-1102
26. Roscic A., Baldo B., Crochemore C., Marcellin D., Paganetti P., Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model. Journal of Neurochemistry 2011 119 398 407 10.1111/j.1471-4159.2011.07435.x
27. Li X., Wang C. E., Huang S., Xu X., Li X. J., Li H., Li S., Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments. Human Molecular Genetics 2010 19 12 2445 2455 2-s2.0-77955291545 10.1093/hmg/ddq127 ddq127
28. Hershko A., Ciechanover A., The ubiquitin system. Annual Review of Biochemistry 1998 67 425 479 2-s2.0-0031657807 10.1146/annurev.biochem.67.1.425
29. Glickman M. H., Ciechanover A., The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiological Reviews 2002 82 2 373 428 2-s2.0-0036083396
30. Voges D., Zwickl P., Baumeister W., The 26S proteasome: a molecular machine designed for controlled proteolysis. Annual Review of Biochemistry 1999 68 1015 1068 2-s2.0-0032867676 10.1146/annurev.biochem.68.1.1015
31. Smith D. M., Kafri G., Cheng Y., Ng D., Walz T., Goldberg A. L., ATP binding to PAN or the 26S ATPases causes association with the 20S proteasome, gate opening, and translocation of unfolded proteins. Molecular Cell 2005 20 5 687 698 2-s2.0-28444452611 10.1016/j.molcel.2005.10.019
32. Bar-Nun S., Glickman M. H., Proteasomal AAA-ATPases: structure and function. Biochimica Et Biophysica Acta 2012 1823 67 82 10.1016/j.bbamcr.2011. 07.009
33. Groll M., Ditzel L., Löwe J., Stock D., Bochtler M., Bartunik H. D., Huber R., Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature 1997 386 6624 463 471 2-s2.0-0030897031 10.1038/386463a0
34. Lowe J., Stock D., Jap B., Zwickl P., Baumeister W., Huber R., Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution. Science 1995 268 5210 533 539 2-s2.0-0029042511
35. Unno M., Mizushima T., Morimoto Y., Tomisugi Y., Tanaka K., Yasuoka N., Tsukihara T., The structure of the mammalian 20S proteasome at 2.75 Å resolution. Structure 2002 10 5 609 618 2-s2.0-0036103598 10.1016/S0969-2126(02) 00748-7
36. Arendt C. S., Hochstrasser M., Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation. Proceedings of the National Academy of Sciences of the United States of America 1997 94 14 7156 7161 2-s2.0-0030737501 10.1073/pnas.94.14.7156
37. Seemuller E., Lupas A., Zuhl F., Zwickl P., Baumeister W., The proteasome from Thermoplasma acidophilum is neither a cysteine nor a serine protease. FEBS Letters 1995 359 173 178 10.1016/0014-5793(95)00036-9
38. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S. W., Bates G. P., Exon I of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996 87 3 493 506 2-s2.0-16044373842 10.1016/S0092-8674(00)81369-0
39. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L., Bates G. P., Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997 90 3 537 548 2-s2.0-18544410106 10.1016/S0092-8674(00)80513-9
40. Waelter S., Boeddrich A., Lurz R., Scherzinger E., Lueder G., Lehrach H., Wanker E. E., Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Molecular Biology of the Cell 2001 12 5 1393 1407 2-s2.0-0034754875
41. Kalchman M. A., Graham R. K., Xia G., Brook Koide H., Graeme Hodgson J., Graham K. C., Paul Goldberg Y., Dan Gietz R., Pickart C. M., Hayden M. R., Huntingtin is ubiquitinated and interacts with a specific ubiquitin- conjugating enzyme. Journal of Biological Chemistry 1996 271 32 19385 19394 2-s2.0-9444239187 10.1074/jbc.271.32.19385
42. Iwata A., Nagashima Y., Matsumoto L., Suzuki T., Yamanaka T., Date H., Deoka K., Nukina N., Tsuji S., Intranuclear degradation of polyglutamine aggregates by the ubiquitin-proteasome system. Journal of Biological Chemistry 2009 284 15 9796 9803 2-s2.0-65649121163 10.1074/jbc.M809739200
43. Thompson L. M., Aiken C. T., Kaltenbach L. S., Agrawal N., Illes K., Khoshnan A., Martinez-Vincente M., Arrasate M., O'Rourke J. G., Khashwji H., Lukacsovich T., Zhu Y. Z., Lau A. L., Massey A., Hayden M. R., Zeitlin S. O., Finkbeiner S., Green K. N., LaFerla F. M., Bates G., Huang L., Patterson P. H., Lo D. C., Cuervo A. M., Marsh J. L., Steffan J. S., IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. Journal of Cell Biology 2009 187 7 1083 1099 2-s2.0-72149124383 10.1083/jcb.200909067
44. Hipp M. S., Patel C. N., Bersuker K., Riley B. E., Kaiser S. E., Shaler T. A., Brandeis M., Kopito R. R., Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease. The Journal of Cell Biology 2012 196 573 587 10.1083/jcb.201110093
45. Venkatraman P., Wetzel R., Tanaka M., Nukina N., Goldberg A. L., Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Molecular Cell 2004 14 1 95 104 2-s2.0-1842766144 10.1016/S1097-2765(04)00151-0
46. Kisselev A. F., Akopian T. N., Woo K. M., Goldberg A. L., The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. Journal of Biological Chemistry 1999 274 6 3363 3371 2-s2.0-0033525086 10.1074/jbc.274.6.3363
47. Holmberg C. I., Staniszewski K. E., Mensah K. N., Matouschek A., Morimoto R. I., Inefficient degradation of truncated polyglutamine proteins by the proteasome. The EMBO Journal 2004 23 21 4307 4318 2-s2.0-9144223729 10.1038/sj.emboj.7600426
48. Raspe M., Gillis J., Krol H., Krom S., Bosch K., van Veen H., Reits E., Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity. Journal of Cell Science 2009 122 18 3262 3271 2-s2.0-70350380897 10.1242/jcs.045567
49. Bhutani N., Venkatraman P., Goldberg A. L., Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation. The EMBO Journal 2007 26 5 1385 1396 2-s2.0-33947164372 10.1038/sj.emboj.7601592
50. Menzies F. M., Hourez R., Imarisio S., Raspe M., Sadiq O., Chandraratna D., O'Kane C., Rock K. L., Reits E., Goldberg A. L., Rubinsztein D. C., Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy. Human Molecular Genetics 2010 19 23 4573 4586 2-s2.0-78149277418 10.1093/hmg/ddq385
51. Hunter J. M., Lesort M., Johnson G. V. W., Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease. Journal of Neuroscience Research 2007 85 8 1774 1788 2-s2.0-34249802905 10.1002/jnr.21287
52. Seo H., Sonntag K. C., Isacson O., Generalized brain and skin proteasome inhibition in Huntington's disease. Annals of Neurology 2004 56 3 319 328 2-s2.0-4444303263 10.1002/ana.20207
53. Jana N. R., Zemskov E. A., Wang G. H., Nukina N., Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Human Molecular Genetics 2001 10 10 1049 1059 2-s2.0-0035336658
54. Gilon T., Chomsky O., Kulka R. G., Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae. The EMBO Journal 1998 17 10 2759 2766 2-s2.0-0032525130 10.1093/emboj/17.10.2759
55. Bence N. F., Sampat R. M., Kopito R. R., Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001 292 5521 1552 1555 2-s2.0-0035947372 10.1126/science.292.5521.1552
56. Bennett E. J., Bence N. F., Jayakumar R., Kopito R. R., Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Molecular Cell 2005 17 3 351 365 2-s2.0-13244258435 10.1016/j.molcel.2004.12.021
57. Hoyt M. A., Zhang M., Coffino P., Probing the ubiquitin/proteasome system with ornithine decarboxylase, a ubiquitin-independent substrate. Methods in Enzymology 2005 398 399 413 2-s2.0-27644580299 10.1016/S0076-6879(05)98033-6
58. Rousseau E., Kojima R., Hoffner G., Djian P., Bertolotti A., Misfolding of proteins with a polyglutamine expansion is facilitated by proteasomal chaperones. Journal of Biological Chemistry 2009 284 3 1917 1929 2-s2.0-59449084849 10.1074/jbc.M806256200
59. Michalik A., Van Broeckhoven C., Proteasome degrades soluble expanded polyglutamine completely and efficiently. Neurobiology of Disease 2004 16 1 202 211 2-s2.0-2342485108 10.1016/j.nbd.2003.12.020
60. Weinhofer I., Forss-Petter S., Žigman M., Berger J., Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. Human Molecular Genetics 2002 11 22 2689 2700 2-s2.0-0037108725
61. Dantuma N. P., Lindsten K., Glas R., Jellne M., Masucci M. G., Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome- dependent proteolysis in living cells. Nature Biotechnology 2000 18 5 538 543 2-s2.0-0034023407 10.1038/75406
62. Varshavsky A., The N-end rule pathway of protein degradation. Genes to Cells 1997 2 1 13 28 2-s2.0-0030632048
63. Díaz-Hernández M., Hernández F., Martín-Aparicio E., Gómez-Ramos P., Morán M. A., Castaño J. G., Ferrer I., Avila J., Lucas J. J., Neuronal Induction of the Immunoproteasome in Huntington's Disease. Journal of Neuroscience 2003 23 37 11653 11661 2-s2.0-0347064159
64. Maynard C. J., Böttcher C., Ortega Z., Smith R., Florea B. I., Díaz-Hernández M., Brundin P., Overkleeft H. S., Li J. Y., Lucas J. J., Dantuma N. P., Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment. Proceedings of the National Academy of Sciences of the United States of America 2009 106 33 13986 13991 2-s2.0-69549131138 10.1073/pnas.0906463106
65. Bett J. S., Goellner G. M., Woodman B., Pratt G., Rechsteiner M., Bates G. P., Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG γ as a therapeutic target. Human Molecular Genetics 2006 15 1 33 44 2-s2.0-32144453469 10.1093/hmg/ddi423
66. Díaz-Hernández M., Valera A. G., Morán M. A., Gómez-Ramos P., Alvarez-Castelao B., Castaño J. G., Hernández F., Lucas J. J., Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain. Journal of Neurochemistry 2006 98 5 1585 1596 2-s2.0-33746932115 10.1111/j.1471-4159.2006.03968.x
67. Mitra S., Tsvetkov A. S., Finkbeiner S., Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in Huntington disease. Journal of Biological Chemistry 2009 284 7 4398 4403 2-s2.0-63249135140 10.1074/jbc.M806269200
68. Ortega Z., Díaz-Hernández M., Maynard C. J., Hernández F., Dantuma N. P., Lucas J. J., Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation. Journal of Neuroscience 2010 30 10 3675 3688 2-s2.0-77949352928 10.1523/JNEUROSCI.5673-09.2010
69. Wenzel T., Baumeister W., Conformational constrains in protein degradation by the 20S proteasome. Nature Structural Biology 1995 2 3 199 204 2-s2.0-0028985861
70. Johnston S. C., Whitby F. G., Realini C., Rechsteiner M., Hill C. P., The proteasome 11S regulator subunit REG α (PA28 α) is a heptamer. Protein Science 1997 6 11 2469 2473 2-s2.0-0030685161
71. Knowlton J. R., Johnston S. C., Whitby F. G., Realini C., Zhang Z., Rechsteiner M., Hill C. P., Structure of the proteasome activator REG α (PA28 α). Nature 1997 390 6660 639 643 2-s2.0-0031456970 10.1038/37670
72. Zhang Z., Krutchinsky A., Endicott S., Realini C., Rechsteiner M., Standing K. G., Proteasome activator 11S REG or PA28: recombinant REG α /REG β hetero- oligomers are heptamers. Biochemistry 1999 38 17 5651 5658 2-s2.0-0033608969 10.1021/bi990056+
73. Förster A., Masters E. I., Whitby F. G., Robinson H., Hill C. P., The 1.9 Å structure of a proteasome-11S activator complex and implications for proteasome-PAN/PA700 interactions. Molecular Cell 2005 18 5 589 599 2-s2.0-19444387760 10.1016/j.molcel.2005.04.016
74. Chu-Ping M., Slaughter C. A., DeMartino G. N., Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). Journal of Biological Chemistry 1992 267 15 10515 10523 2-s2.0-0026669739
75. Dubiel W., Pratt G., Ferrell K., Rechsteiner M., Purification of an 11 S regulator of the multicatalytic protease. Journal of Biological Chemistry 1992 267 31 22369 22377 2-s2.0-0026498493
76. Ustrell V., Pratt G., Rechsteiner M., Effects of interferon γ and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases. Proceedings of the National Academy of Sciences of the United States of America 1995 92 2 584 588 2-s2.0-0028890880 10.1073/pnas.92.2.584
77. Ahn J. Y., Tanahashi N., Akiyama K. Y., Hisamatsu H., Noda C., Tanaka K., Chung C. H., Shibmara N., Willy P. J., Mott J. D., Slaughter C. A., DeMartino G. N., Primary structures of two homologous subunits of PA28, a γ -interferon-inducible protein activator of the 20S proteasome. FEBS Letters 1995 366 1 37 42 2-s2.0-0029000418 10.1016/0014-5793(95)00492-R
78. Groettrup M., Soza A., Eggers M., Kuehn L., Dick T. P., Schild H., Rammensee H. G., Koszinowski U. H., Kloetzel P. M., A role for the proteasome regulator PA28 α in antigen presentation. Nature 1996 381 6578 166 168 2-s2.0-0029918289
79. Realini C., Jensen C. C., Zhang Z. G., Johnston S. C., Knowlton J. R., Hill C. P., Rechsteiner M., Characterization of recombinant REG α REG β and REG γ proteasome activators. Journal of Biological Chemistry 1997 272 41 25483 25492 2-s2.0-0030611045 10.1074/jbc.272.41.25483
80. Dick T. P., Ruppert T., Groettrup M., Kloetzel P. M., Kuehn L., Koszinowski U. H., Stevanović S., Schild H., Rammensee H. G., Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 1996 86 2 253 262 2-s2.0-0030602834 10.1016/S0092-8674(00)80097-5
81. Whitby F. G., Masters E. I., Kramer L., Knowlton J. R., Yao Y., Wang C. C., Hill C. P., Structural basis for the activation of 20S proteasomes by 11S regulators. Nature 2000 408 6808 115 120 2-s2.0-0034597824 10.1038/35040607
82. Mao I., Liu J., Li X., Luo H., REG γ a proteasome activator and beyond? Cellular and Molecular Life Sciences 2008 65 24 3971 3980 2-s2.0-58149115206 10.1007/s00018-008-8291-z
83. Rechsteiner M., Hill C. P., Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends in Cell Biology 2005 15 1 27 33 2-s2.0-11844287006 10.1016/j.tcb.2004.11.003
84. Gao X., Li J., Pratt G., Wilk S., Rechsteiner M., Purification procedures determine the proteasome activation properties of REG γ (PA28 γ). Archives of Biochemistry and Biophysics 2004 425 2 158 164 2-s2.0-2142715911 10.1016/j.abb.2004.03.021
85. Li J., Gao X., Ortega J., Nazif T., Joss L., Bogyo M., Steven A. C., Rechsteiner M., Lysine 188 substitutions convert the pattern of proteasome activation by REG γ to that of REGs α and β The EMBO Journal 2001 20 13 3359 3369 2-s2.0-0035796464 10.1093/emboj/20.13.3359
86. Zhou P., REG γ: a shortcut to destruction. Cell 2006 124 2 256 257 2-s2.0-31044439969 10.1016/j.cell.2006.01.003
87. Harris J. L., Alper P. B., Li J., Rechsteiner M., Backes B. J., Substrate specificity of the human proteasome. Chemistry and Biology 2001 8 12 1131 1141 2-s2.0-0035542852 10.1016/S1074-5521(01)00080-1
88. Hendil K. B., Khan S., Tanaka K., Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes. Biochemical Journal 1998 332 3 749 754 2-s2.0-0032526238
89. Gray C. W., Slaughter C. A., DeMartino G. N., PA28 activator protein forms regulatory caps on proteasome stacked rings. Journal of Molecular Biology 1994 236 1 7 15 2-s2.0-0028300177 10.1006/jmbi.1994.1113
90. Cascio P., Call M., Petre B. M., Walz T., Goldberg A. L., Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes. The EMBO Journal 2002 21 11 2636 2645 2-s2.0-0037013955 10.1093/emboj/21.11.2636
91. Tanahashi N., Murakami Y., Minami Y., Shimbara N., Hendil K. B., Tanaka K., Hybrid proteasomes. Induction by interferon- γ and contribution to ATP- dependent proteolysis. Journal of Biological Chemistry 2000 275 19 14336 14345 2-s2.0-0034640520 10.1074/jbc.275.19.14336
92. Rechsteiner M., Realini C., Ustrell V., The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochemical Journal 2000 345 1 1 15 2-s2.0-0033965851 10.1042/0264-6021:3450001
93. Pratt G., Rechsteiner M., Proteasomes cleave at multiple sites within polyglutamine tracts: activation by PA28 γ (K188E). Journal of Biological Chemistry 2008 283 19 12919 12925 2-s2.0-45149115090 10.1074/jbc.M709347200
94. Seo H., Sonntag K. C., Kim W., Cattaneo E., Isacson O., Proteasome activator enhances survival of Huntington's disease neuronal model cells. PLoS One 2007 2 2, article no. e238 2-s2.0-34948845308 10.1371/journal.pone.0000238
95. Barton L. F., Runnels H. A., Schell T. D., Cho Y., Gibbons R., Tevethia S. S., Deepe G. S., Monaco J. J., Immune defects in 28-kDa proteasome activator γ -deficient mice. Journal of Immunology 2004 172 6 3948 3954 2-s2.0-1542724417
96. Krüger E., Kuckelkorn U., Sijts A., Kloetzel P. M., The components of the proteasome system and their role in MHC class I antigen processing. Reviews of Physiology, Biochemistry and Pharmacology 2003 148 81 104 2-s2.0-0842277344
97. Heink S., Ludwig D., Kloetzel P. M., Krüger E., IFN- γ -induced immune adaptation of the proteasome system is an accelerated and transient response. Proceedings of the National Academy of Sciences of the United States of America 2005 102 26 9241 9246 2-s2.0-21544475903 10.1073/pnas.0501711102
98. Aki M., Shimbara N., Takashina M., Akiyama K., Kagawa S., Tamura T., Tanabashi N., Yoshimura T., Tanaka K., Ichihara A., Interferon- γ induces different subunit organizations and functional diversity of proteasomes. Journal of Biochemistry 1994 115 2 257 269 2-s2.0-0028179233
99. Driscoll J., Brown M. G., Finley D., Monaco J. J., MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 1993 365 6443 262 264 2-s2.0-0027223877 10.1038/365262a0
100. Gaczynska M., Rock K. L., Goldberg A. L., γ -Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993 365 6443 264 267 2-s2.0-0027214605 10.1038/365264a0
101. Boes B., Hengel H., Ruppert T., Multhaup G., Koszinowski U. H., Kloetzel P. M., Interferon γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. Journal of Experimental Medicine 1994 179 3 901 909 2-s2.0-0028097823
102. Kuckelkorn U., Frentzel S., Kraft R., Kostka S., Groettrup M., Kloetzel P. M., Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon- γ European Journal of Immunology 1995 25 9 2605 2611 2-s2.0-0029162601 10.1002/eji.1830250930
103. Pickering A. M., Koop A. L., Teoh C. Y., Ermak G., Grune T., Davies K. J. A., The immunoproteasome, the 20S proteasome and the PA28 α β proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochemical Journal 2010 432 3 585 594 2-s2.0-78649848069 10.1042/BJ20100878
104. Seifert U., Bialy L. P., Ebstein F., Bech-Otschir D., Voigt A., Schröter F., Prozorovski T., Lange N., Steffen J., Rieger M., Kuckelkorn U., Aktas O., Kloetzel P. M., Krüger E., Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 2010 142 4 613 624 2-s2.0-77955596988 10.1016/j.cell.2010.07.036
105. Reits E. A. J., Vos J. C., Grammé M., Neefjes J., The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 2000 404 6779 774 778 2-s2.0-0034643348 10.1038/35008103
106. Yewdell J. W., The seven dirty little secrets of major histocompatibility complex class I antigen processing. Immunological Reviews 2005 207 8 18 2-s2.0-26244435436 10.1111/j.0105-2896.2005.00309.x
107. Kaur S., Sassano A., Dolniak B., Joshi S., Majchrzak-Kita B., Baker D. P., Hay N., Fish E. N., Platanias L. C., Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proceedings of the National Academy of Sciences of the United States of America 2008 105 12 4808 4813 2-s2.0-42449150892 10.1073/pnas.0710907105
108. Díaz-Hernández M., Martín-Aparicio E., Avila J., Hernández F., Lucas J. J., Enhaced induction of the immunoproteasome by interferon gamma in neurons expressing mutant huntingtin. Neurotoxicity Research 2004 6 6 463 468 2-s2.0-13944283365 10.1007/BF03033282
109. Ortega Z., Díaz-Hernández M., Lucas J. J., Is the ubiquitin-proteasome system impaired in Huntington's disease? Cellular and Molecular Life Sciences 2007 64 17 2245 2257 2-s2.0-34548331451 10.1007/s00018-007-7222-8
110. Chai Y., Koppenhafer S. L., Bonini N. M., Paulson H. L., Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. Journal of Neuroscience 1999 19 23 10338 10347 2-s2.0-0033499931
111. Jana N. R., Tanaka M., Wang G. H., Nukina N., Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Human Molecular Genetics 2000 9 13 2009 2018 2-s2.0-0034641589
112. Hageman J., Rujano M. A., van Waarde M. A. W. H., Kakkar V., Dirks R. P., Govorukhina N., Oosterveld-Hut H. M. J., Lubsen N. H., Kampinga H. H., A DNAJB dependent activities suppresses toxic protein aggregation. Molecular Cell 2010 37 3 355 369 2-s2.0-75949094261 10.1016/j.molcel.2010.01.001
113. Bailey C. K., Andriola I. F. M., Kampinga H. H., Merry D. E., Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Human Molecular Genetics 2002 11 5 515 523 2-s2.0-0036501074
114. Kazantsev A., Walker H. A., Slepko N., Bear J. E., Preisinger E., Steffan J. S., Zhu Y. Z., Gertler F. B., Housman D. E., Marsh J. L., Thompson L. M., A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila. Nature Genetics 2002 30 4 367 376 2-s2.0-18544379477 10.1038/ng864